Study on the conversion of novel drug potassium 2-(1-hydroxypentyl)-benzoate (dl-phpb), a pro-drug of 3-n-butylphthalide (dl-nbp)

• In: SIG Bioavailability/Bioequivalence - Posters
• At: Beijing (China) (2007)
• Type: Poster
• Poster code: BB-P-004
• By: JIANG, Li (Institute of Meteria Medica, Beijing, China)
• Co-author(s): XU, shaofeng (Institute of Meteria Medica, BEIJING, China)
  Wang, ling (Institute of Meteria Medica, BEIJING, China)
  Wang, xiaoliang (Institute of Meteria Medica, BEIJING, China)
  
• Abstract:

  Dl-NBP is a novel agent for treatment of brain ischemia. PHPB, a potential prodrug of dl-NBP, was designed to increase water solubility of dl-NBP, which can be administrated intravenously and orally. The conversion of PHPB to dl-NBP was investigated in vitro and in vivo. To determine the level of PHPB and active drug dl-NBP, the HPLC method was..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login